Bank Of Nova Scotia Abb Vie Inc. Transaction History

Bank Of Nova Scotia

$47.4 Billion
Q3 2024

A detailed history of Bank Of Nova Scotia transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 837,148 shares of ABBV stock, worth $147 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

837,148

Previous 962,239 13.0%

Holding current value

$147 Million

Previous $165 Million 0.17%

% of portfolio

0.35%

Previous 0.29%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $20.5 Million - $24.9 Million	-125,091 Reduced 13.0%	837,148 $165 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $13.4 Million - $15.6 Million	86,501 Added 9.88%	962,239 $165 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $38.8 Million - $44.2 Million	-242,565 Reduced 21.69%	875,738 $159 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $16.3 Million - $18.3 Million	118,379 Added 11.84%	1,118,303 $173 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $4.7 Million - $5.44 Million	-35,205 Reduced 3.4%	999,924 $149 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $19 Million - $23.6 Million	-143,131 Reduced 12.15%	1,035,129 $139 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $24.5 Million - $28.3 Million	169,705 Added 16.83%	1,178,260 $188 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $24.2 Million - $29 Million	174,935 Added 20.98%	1,008,555 $163 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $4.38 Million - $5.03 Million	-32,652 Reduced 3.77%	833,620 $112 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $112 Million - $143 Million	814,745 Added 1581.2%	866,272 $133 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $140 Million - $177 Million	-1,013,864 Reduced 95.16%	51,527 $7.89 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $8.94 Million - $11.1 Million	-67,729 Reduced 5.98%	1,065,391 $173 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $27.3 Million - $34.5 Million	253,978 Added 28.89%	1,133,120 $153 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $10.7 Million - $12.2 Million	100,994 Added 12.98%	879,142 $94.8 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $81.9 Million - $91.2 Million	778,148 New	778,148 $87.7 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Abb Vie Inc. Transaction History